Aminotetraline derivatives, pharmaceutical compositions...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 215/70 (2006.01) A61K 31/16 (2006.01) A61P 25/00 (2006.01) C07C 233/00 (2006.01) C07C 311/00 (2006.01) C07C 317/00 (2006.01) C07D 213/71 (2006.01) C07D 231/18 (2006.01) C07D 233/84 (2006.01) C07D 249/12 (2006.01) C07D 261/08 (2006.01) C07D 275/02 (2006.01) C07D 305/08 (2006.01) C07D 333/04 (2006.01) C07F 7/10 (2006.01)

Patent

CA 2750793

The present invention relates to aminotetraline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline derivatives, and the use of such aminotetraline derivatives for therapeutic purposes. The aminotetraline derivatives are GIyT1 inhibitors.

La présente invention porte sur des dérivés d'aminotétraline représentés par la formule (I) ou un sel physiologiquement toléré desdits dérivés. L'invention porte sur des compositions pharmaceutiques contenant de tels dérivés d'aminotétraline et sur l'utilisation de tels dérivés d'aminotétraline à des fins thérapeutiques. Les dérivés d'aminotétraline sont des inhibiteurs de GlyT1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aminotetraline derivatives, pharmaceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminotetraline derivatives, pharmaceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminotetraline derivatives, pharmaceutical compositions... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1853982

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.